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ABSTRACT
Several gastrointestinal diseases show a sex imbalance, although the underlying (patho)physio-
logical mechanisms behind this are not well understood. The gut microbiome may be involved in
this process, forming a complex interaction with host immune system, sex hormones, medication
and other environmental factors. Here we performed sex-specific analyses of fecal microbiota
composition in 1135 individuals from a population-based cohort. The overall gut microbiome
composition of females and males was significantly different (p = 0.001), with females showing a
greater microbial diversity (p = 0.009). After correcting for the effects of intrinsic factors, smoking,
diet and medications, female hormonal factors such as the use of oral contraceptives and under-
going an ovariectomy were associated with microbial species and pathways. Females had a higher
richness of antibiotic-resistance genes, with the most notable being resistance to the lincosamide
nucleotidyltransferase (LNU) gene family. The higher abundance of resistance genes is consistent
with the greater prescription of the Macrolide-Lincosamide-Streptogramin classes of antibiotics to
females. Furthermore, we observed an increased resistance to aminoglycosides in females with
self-reported irritable bowel syndrome. These results throw light upon the effects of common
medications that are differentially prescribed between sexes and highlight the importance of sex-
specific analysis when studying the gut microbiome and resistome.
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Sex differences are often seen in the prevalence and
clinical manifestations of several gastrointestinal
(GI) diseases,1 particularly functional GI disorders
like irritable bowel syndrome (IBS).2 The influence
of genetics and environmental factors, including use
of antibiotics3 and dietary habits,4 on the prevalence
of GI diseases has also been shown.5 Although bio-
logical sex is often used as a covariate in statistical
association analyses, it is the involvement of sex
hormones that is usually evoked to explain sex-spe-
cific disease risk effects,6-8 although this is seldom
formally tested. Furthermore, the intrinsic factors
and sex-specific pathophysiological mechanisms
underlying sex differences in GI diseases in humans
have been poorly characterized so far. Using mouse
studies, Markle et al. have shown that microbiome
manipulations can provoke hormonal-dependent
protection from autoimmunity.9 Such studies reveal
the complex interaction between the host immune
system, the gutmicrobiota and the function of innate
and adaptive immunity. In this article we focus on
the gut microbiome as one of the possible factors
involved in the differential prevalence of GI diseases.
The gut microbiome contributes greatly to host
well-being, and specific changes in its composition
have been consistently associated with modulatory
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effects on gut function and behavior, as well as with
several diseases.10,11 Among the known factors
affecting human gut microbiota composition –
including age, BMI, smoking, diet, medication,
illnesses and genetics12 – sex is one factor that has
never been extensively studied. Differences in the
composition of male and female gut microbiota
have been reported in human and animal models,8,9
and these may be relevant to disease susceptibility.
However, sex-focused human microbiota studies
have only been carried out in relatively small samples
(n < 100), have generated rather conflicting results,
and have not attempted to distinguish between
intrinsic (biological) versus extrinsic (environmen-
tal) components.13 In addition, in human studies,
there is often little information about hormonal fac-
tors and their association with gut microbiome.
Furthermore, the differential use of medications by
men and women may also be one of the key factors
contributing to sex-specific microbiota profiles,
although this too has not been adequately investi-
gated. We therefore aimed to identify sex differences
in gut microbiome composition (including function-
ality and antibiotic-resistance genes), focusing on
medication use while also taking into account the
effects of environmental and female-specific factors
on the gut microbiome.
Methods
Cohort information
We collected data from a general population-
based cohort: LifeLines-DEEP (LLD, n = 1,179,
58.2% females, mean age 44.6 years [range
18–81 years]). LLD is part of the LifeLines
study, a prospective, general-population-based
cohort comprising more than 167,000 partici-
pants residing in the three northern provinces
of the Netherlands.14 Biomaterials were col-
lected and biological measurements made for
the LifeLines study, as described previously.15
Questionnaires
Extensive information on demographics, health,
lifestyle, and diet was collected via detailed ques-
tionnaires as described previously.14,15
Metagenomic sequencing
All participants collected stool samples at home.
Samples were placed in the participant’s home free-
zer directly after stool collection. The samples were
collected on dry ice by a nurse and stored at −80°C.
Aliquots were then made and DNA was extracted
using the AllPrep DNA/RNA Mini Kit (Qiagen; cat.
#80204) with the addition of mechanical lysis.9
Metagenomic sequencing was performed using shot-
gun sequencing at the Broad Institute, Boston, and
was followed by sequence read quality control using
their in-house pipeline. Samples with a read depth
less than 15 million reads were excluded from
further analyses (n = 44). Next, sequencing adapters
and human DNA contamination were removed as
described previously.12,15
Identifying microbial taxonomy and metabolic
pathways
The shotgun sequencing of microbial genomes
allowed us to not only identify microbes, but also to
explore the presence of potentially interesting genes
and predict their functions. To determine the micro-
bial profile of each sample, the sequences were
mapped to approximately 1 million clade-specific
marker genes using MetaPhlan 2.2. The metabolic
potential of themicrobial community was determined
using HUMAnN2 (Human Microbiome Project
Unified Metabolic Analysis Network, version 2)16
with MetaCyc17 as a reference database.
Antibiotic-resistance genes
The abundance of antibiotic-resistance (AR) pro-
teins was detected and quantified in each sample
using ShortBRED18 with the default parameters.
This database was provided with the software con-
taining AR-marker sequences created from the
Comprehensive Antibiotic Resistance Database
(CARD) was used as a reference.19
Statistical analysis
Microbial diversity within individuals, represented
as Shannon’s index value, was calculated per sample
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using the diversity function in the R package ‘vegan’
(version 2.4–2).20 We used the Wilcoxon rank sum
test to assess the difference in diversity between
males and females. Differences were considered
significant at FDR < 0.05. The differences in the
overall microbial composition between samples
were calculated as Bray-Curtis distances using the
vegdist function from the same package. To test
how much of the inter-individual microbial varia-
tion (as Bray-Curtis and Jaccard distances) could
be explained by sex, we then performed a
PERMANOVA (permutational multivariate analy-
sis of variance) using the adonis function from this
package. The P-value was determined by 1000 per-
mutations, and differences were considered signifi-
cant at p < 0.05. Homogeneity of the dispersions
within sex groups was checked using the bedadisper
function with the ‘centroid’ type of analysis. The
significance of differences was estimated by permut-
est function using 1000 permutations. Both
PERMANOVA and homogeneity dispersion tests
were applied to the dissimilarity matrices calculated
on taxonomic (species) and functional (microbial
pathway) level.
The statistical program Multivariate Association
with LinearModels (MaAsLin)21 was used to associate
the available metadata with microbial relative abun-
dances at species level and MetaCyc pathways.
MaAsLin performs boosted, additive, general linear
models between metadata or phenotypes, treating
them as predictor factors, and the response, for exam-
ple, microbial features (taxa and pathways relative
abundances).22 After allowing for the influence of
diet, intrinsic factors, disease and smoking in a multi-
variate model, we assessed the relation between sex
and relativemicrobial abundances andMetaCyc path-
ways. The factors added to the analyses were the ones
which had a significant influence on the Bray-Curtis
distance. We corrected for 83 factors that influenced
the overall gut microbiome composition (beta-diver-
sity) (Supplementary table 2) after removing 11 factors
that showed high correlation (Spearman’s rho > 0.8).
In each analysis, the false discovery rate (FDR) was
controlled using the Benjamini-Hochberg (BH) pro-
cedure at the level of 0.05. To test the association for
each microbial species and pathway, we confined our
analysis to those that were present in at least 5% of the
participants. The microbial abundance and MetaCyc
pathways were normalized using arcsin-square-root
transformation before association analysis with
MaAsLin.
To analyze the differences in AR between males
and females we used ShortBRED.18 Of the 1135
individuals included in this study, 13 had used
antibiotics in the 3 months prior to sample collec-
tion, and these 13 participants were excluded from
the resistome analyses. We first filtered out AR
proteins, classes and mechanisms present in less
than 5% of our LLD population cohort. We then
converted the data to absence/presence and per-
formed logistic regression of sex with each AR
protein/class, including age and read depth as
covariates. In model 1 we showed the result of
the logistic regression of sex with AR protein/
class and mechanism, taking into the account the
effect of both age and read depth. In model 2 we
showed the association of sex with each AR pro-
tein/class and mechanism, adding age or read
depth only if there was a significant relationship
in model 1. In all tests we considered differences
with BH FDR< 0.05 as significant. Spearman cor-
relations were used to assess the relation between
the bacterial abundances and the abundances of
antibiotic resistance genes (represented as reads
per kilobase of reference sequence per million
sample reads (RPKMs)). The scripts for data ana-
lysis can be found on: https://doi.org/10.5281/
zenodo.1445439
Results and discussion
We studied 661 women and 474 men from the
LLD population-based cohort (described pre-
viously, with detailed phenotypic data and fecal
metagenomic sequencing data.12) The mean
(± SD) age of participants was 45.0 years
(± 13.6), with no significant difference between
males and females (p = 0.47). Our gut microbiome
analysis included calculating microbial diversity,
microbial taxonomic composition, bacterial func-
tional pathways, and analysis of the bacterial resis-
tome (the prevalence of antibiotic resistance
genes). Compared to men, women showed a
higher gut microbiome diversity (Shannon
Diversity Index 2.86 ± 0.32 vs 2.91 ± 0.32, respec-
tively; p = 0.009). A statistical analysis of the inter-
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individual variation also indicated that the overall
gut microbiome taxonomic and functional compo-
sition was significantly different between the sexes
(both Bray-Curtis and Jaccard p = 0.001). Females
showed slightly larger within-group beta disper-
sion compared to males (p = 0.001), while the
dispersion difference was not significant on func-
tional level (p = 0.42). Sex was significantly asso-
ciated with 12 microbial species and 43 metabolic
pathways (Supplementary table 1). Since many
dietary, lifestyle, medication and other factors are
different between men and women, we corrected
for 83 environmental and intrinsic factors that are
known to influence gut microbial composition
(Supplementary table 2). After correction for all
these factors, Akkermansia muciniphila was still
found to be associated with sex (FDR = 0.002),
with females having a higher abundance of this
species. A. muciniphila has previously been asso-
ciated with healthier glucose metabolism and lean-
ness in mice and humans23,24 and, given its sex-
associated differential abundance, may play a lar-
ger protective role against the development of
insulin resistance and diabetes in females. Female
hormones are also known to play a protective role
in the development of insulin resistance, with
women showing a lower incidence of insulin resis-
tance than men of a similar age prior to
menopause.25 Despite these observations, sex
explained only 0.5% of the total variation in gut
microbial composition (Supplementary table 2),
consistent with previous findings showing that
environmental factors, including the use of certain
medications, have stronger effects on microbiome
composition.26–29
In order to determine the individual components
of medication-use that influence gut microbiome
composition, we initially focused on female-specific
hormone-related factors, such as the use of oral con-
traceptives (Supplementary table 3). In women, use of
hormonal contraception was associated with signifi-
cant differences in both microbial species abundance
and functional pathways (Supplementary table 4),
after correcting for 83 factors influencing gut micro-
biome composition. However, these associations did
not overlap with sex-specific ones, and therefore we
could not explain the differences in microbial species
and pathways betweenmales and females through our
available hormonal phenotypes.
We did, however, find bacterial species that were
associated with hormonal factors after correcting for
83 factors that influence gut microbiome composition
(Supplementary table 4). Anti-androgen oral contra-
ceptives were positively associated with two bacterial
species: Bacteroides caccae (beta-coefficient = 0.05,
FDR = 0.001) and Coprobacillus unclassified (beta-
coefficient = 0.02, FDR = 0.003). Oral contraceptives
were associated with an increase in the species Rothia
mucilaginosa (beta-coefficient = 0.004, FDR = 0.005),
a species normally found in the human mouth and
upper respiratory tract.30,31 This species has also been
shown to be increased in young patients with ulcers in
Crohn’s disease.32 Finally, having had both ovaries
removed was associated with an increase in the
abundance of the species Clostridium bolteae (beta-
coefficient = 0.03, FDR = 0.03) (Supplementary table
4). One of the not infrequent problems that women
face after a bilateral ovariectomy are GI complaints,33
and C. bolteae is known to potentially aggravate GI
symptoms.34 Our result indicates that GI problems
after bilateral ovariectomy might be due to increased
levels of C. bolteae. This is also supported by mouse
studies where bilateral ovariectomy has been revealed
to cause microbial dysbiosis.8,35
In the univariable model, menstruation status
(having regular menstruations) was associated
with higher abundances of Turicibacter sanguinis
and Leuconostoc mesenteroides. However, these
associations ceased to be significant upon adding
age to the model, suggesting that age was driving
these associations. We therefore examined whether
age had a different effect in males versus females,
and found that, although age had a common effect
on Turicibacter and Butyrivibrio species in both
men and women, the association of age with
Streptococcus salivarius was female-specific and
related to the use of hormonal contraceptives
(Supplementary table 5).
When taking into account the medications
used by both sexes, we observed that male LLD
participants took more drugs for heart disease,
while women were more exposed to opiates, laxa-
tives and antibiotics. The last category is of
particular interest, as antibiotics have been
shown to have profound effects on microbiota
composition,27-29,36 and to represent a risk factor
for GI diseases.28 To better characterize the sex-
related differences, we therefore performed (age-
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adjusted) gut metagenomic analyses of resistome
profiles, focusing on AR genes and classes from
CARD. What we found is that men and women
differed significantly in the resistome richness of
their gut microbiome. Females showed a greater
mean prevalence of AR genes (65.4 versus 60.7,
p = 0.004), and this was also reflected at gene
family level (24.0 versus 23.0, p = 0.04). The most
notable difference was observed for the lincosa-
mide nucleotidyltransferase (LNU) gene family,
which was present in 85.98% of women compared
to 79.07% of men (Table 1). In the Netherlands,
lincosamide antibiotics are indicated for bacterial
vaginosis and Pelvic Inflammatory Disease37
(among other conditions), and the prevalence of
women consuming macrolide, lincosamide and
streptogramin (MLS) antibiotics has been consis-
tently higher than that in men during the past
5 years.38 In 2016, MLS antibiotics were con-
sumed by 3.53% of women versus 2.58% of
men. The resistome profiles detected in our
cohort thus appear to follow national trends in
sex-related differences in antibiotic use.
The observed changes in the resistome could not be
linked to the abundance of a specific taxonomy. For
example, the lincosamide nucleotidyltransferase
gene-family found to be more prevalent in females,
has a moderate correlation with the relative abun-
dance of Erysipelotrichaceae bacterium (rho spearman
coefficient = 0.34, FDR < 0.001). The antibiotic resis-
tance genes, TolC and msrB, found to be more pre-
valent in females with IBS were correlated with the
increased abundance of Escherichia coli (Spearman
rho coefficient TolC = 0.63, rho coefficient
msrB = 0.64, FDR< 0.001). Together this suggests
that the antibiotic mechanisms described are shared
between different taxonomic groups.
Antibiotic treatment has been associated with
both increased risk for IBS2 and therapeutic
effects in IBS, both of which are more common
in women.7,39 We therefore sought to test the
potential relevance of the observed sex-specific
resistome differences to (self-reported) IBS. Sex-
stratified analyses of resistome profiles in IBS
versus non-IBS individuals identified eight anti-
biotic resistance genes associated with an
increased risk of IBS in women (see Table 2),
while only the fabI antibiotic resistance
(FDR = 0.02) gene family was more prevalent in
men with IBS. Of note, the most pronounced IBS-
Table 1. Logistic regression of sex with antibiotic-resistance genes, gene families and resistance to antibiotic classes.
ARO ID Present in % of females Present in % of males Effect p value FDR
Antibiotic-resistance genes
ermF ARO:3000498 37.13 28.33 −0.41 0.002 0.080
mel/msrD ARO:3000616 48.23 39.96 −0.34 0.005 0.080
abeM (MATE) ARO:3000753 44.38 37.42 −0.30 0.015 0.080
APH(3’’)-Ib ARO:3002647 88.29 83.30 −0.43 0.015 0.081
lnuC/linC ARO:3002837 85.21 78.44 −0.47 0.003 0.081
lmrC/ydaG ARO:3002881 16.18 10.78 −0.48 0.008 0.081
lmrD/ydbA ARO:3002882 24.96 18.60 −0.38 0.010 0.081
vanRD ARO:3002923 8.32 4.65 −0.66 0.013 0.081
vanWG ARO:3002965 38.06 30.23 −0.36 0.006 0.081
soxG/AcrAB ARO:3003511 27.89 21.35 −0.36 0.011 0.081
MexJ ARO:3003692 10.32 6.13 −0.60 0.010 0.081
Antibiotic gene-families
Lincosamides nucleo. (LNU) 85.98 79.07 −0.49 0.002 0.048
glycopeptide gene cluster 39.45 31.29 −0.36 0.004 0.051
multidrug and toxic compount extrusion (MATE) 46.53 38.90 −0.33 0.007 0.061
ATP-binding cassette (ABC) AB efflux pump 27.89 21.35 −0.36 0.017 0.064
ESP beta-lactamase 7.70 4.44 −0.58 0.02 0.096
rifamycin-resistant (rpoB) 20.96 16.28 −0.34 0.03 0.096
Antibiotic class
lincosamide antibiotic 89.37 84.14 −0.45 0.011 0.055
Carbapenem 12.79 8.03 −0.51 0.014 0.055
Fluoroquinolone 44.38 37.42 −0.30 0.014 0.055
Glycopeptide antibiotic 82.74 76.74 −0.40 0.007 0.055
Sulfonamide antibiotic 38.06 31.50 −0.29 0.020 0.069
Peptide antibiotic 20.96 16.28 −0.34 0.032 0.069
Triclosan 19.11 14.59 −0.33 0.040 0.075
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associated difference was an increased female pre-
valence of APH (3’’)-Ib and APH (6)-Id antibiotic
resistance genes that both belong to the class
aminoglycosides antibiotic resistance. This is par-
ticularly interesting, as it corresponds to the
increased prevalence of antibiotic resistance
genes found in women (with their higher preva-
lence of IBS and its related treatments, including
reported prescriptions of neomycin, an aminogly-
coside class of antibiotics, commonly used for
treating constipation in IBS).39 Given the low
number of men with self-reported IBS (n = 24),
we additionally performed the boostrap-based
estimation of the number of associations of IBS
with antibiotic resistance genes and observed no
systematic difference between groups of males
versus females. Thus we can conclude that the
absence of IBS-determined AR groups in males
is mostly explained by limited power.
In summary, our results link differential
medication use to sex-specific differences in
gut microbiome composition. We show that
hormonal therapy and, possibly, intrinsic hor-
monal factors influence the composition and
function of the gut microbiome in women.
Longitudinal studies are further required to
study the role of intrinsic hormones in gut
microbiome manipulation around menopause.
We show that females have an increased
prevalence of antibiotic resistance genes that
corresponds to national sex differences in con-
sumption of antibiotics. We also show that
females with IBS have a different resistome
profile, and this might be explained by national
trends of differential treatment prescriptions.
Although our analysis in the male cohort
seems to suggest that their IBS resistome differs
from that of females with IBS, this finding is
conditional given the low number of male
cases. Larger clinically characterized IBS
cohorts are needed in order to elucidate the
sex-specific resistome profiles in IBS context.
These results highlight the importance of taking
sex-related factors into account in the analysis
of the human gut microbiome and its interac-
tions with the host in the context of disease.
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